Home
›
Videos
›
Dermbits
›
Primary Endpoint Allegro 2b 3 Trial Ritlecitinib
What was the primary endpoint of the ALLEGRO-2b/3 trial for ritlecitinib?
Featuring:
EJ
E. James Song, MD
Faculty
Updated:
Aug 18, 2026
Alopecia
CME & Education
About Us
Loading profile...
Conditions & Treatments
Learn from the Experts
Support Your Practice
Conferences & Highlights
CME Activities
Educational Resources
Community Resources
Our Expert Network